Roche strengthens digital oncology diagnostics with acquisition of PathAI for $750 million upfront
Roche has signed a definitive merger agreement to acquire digital pathology and artificial intelligence developer PathAI for $750 million upfront and up to $300 million in milestone payments, scaling its automated clinical workflows globally.